178 related articles for article (PubMed ID: 15075086)
21. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
[TBL] [Abstract][Full Text] [Related]
22. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
[TBL] [Abstract][Full Text] [Related]
23. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
[TBL] [Abstract][Full Text] [Related]
24. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia].
Liu L; Yang L; Mi YC; Li JY; Qin TJ; Xu ZF; Zhang Y; Wang JX; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):433-8. PubMed ID: 22213860
[TBL] [Abstract][Full Text] [Related]
26. [Detection of PEBP2 beta/MYH11 fusion mRNA in acute myelomonocytic leukemia without marrow eosinophilia].
Morinaga S; Osato M; Yanabe Y; Takaki K; Kawano F; Asou N; Takatsuki K; Tsuchiya H; Matsuda I
Rinsho Ketsueki; 1996 Jul; 37(7):618-23. PubMed ID: 8779782
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
Reilly JT
Br J Haematol; 2005 Jan; 128(1):18-34. PubMed ID: 15606546
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse.
Sperr WR; Mitterbauer M; Mitterbauer G; Kundi M; Jäger U; Lechner K; Valent P
Clin Cancer Res; 2005 Sep; 11(18):6536-43. PubMed ID: 16166430
[TBL] [Abstract][Full Text] [Related]
30. Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.
Chan NP; Wong WS; Ng MH; Tsang KS; Lau TT; Leung Y; Chik KW; Shing MM; Li CK
Am J Hematol; 2004 Jul; 76(3):300-3. PubMed ID: 15224374
[TBL] [Abstract][Full Text] [Related]
31. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
[TBL] [Abstract][Full Text] [Related]
32. Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report.
McKenna M; Arnold C; Catherwood MA; Humphreys MW; Cuthbert RJ; Bueso-Ramos C; McManus DT
J Clin Pathol; 2009 Aug; 62(8):757-9. PubMed ID: 19638550
[TBL] [Abstract][Full Text] [Related]
33. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four cases.
Weisser M; Haferlach C; Haferlach T; Schnittger S
Cancer Genet Cytogenet; 2007 Aug; 177(1):64-9. PubMed ID: 17693194
[TBL] [Abstract][Full Text] [Related]
35. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
Tobal K; Frost L; Liu Yin JA
Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
[TBL] [Abstract][Full Text] [Related]
36. Assessment of chemosensitivity by monitoring bcl-2 transcript kinetics in acute myeloid leukemias.
Liu K; Kreuzer KA; Lass U; Schmidt CA
Hematol Oncol; 2005 Jun; 23(2):68-72. PubMed ID: 16178036
[TBL] [Abstract][Full Text] [Related]
37. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
38. A case of acute myeloid leukemia with inv(16)(p13q22) reveals a novel MYH11 breakpoint and a new CBF beta-MYH11 transcript variant.
Rowe D; Strain L; Lowe C; Jones G
Haematologica; 2007 Oct; 92(10):1433-4. PubMed ID: 18024381
[TBL] [Abstract][Full Text] [Related]
39. Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML.
Evans PA; Short MA; Jack AS; Norfolk DR; Child JA; Shiach CR; Davies F; Tobal K; Liu Yin JA; Morgan GJ
Leukemia; 1997 Mar; 11(3):364-9. PubMed ID: 9067575
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
Grardel N; Roumier C; Soenen V; Lai JL; Plantier I; Gheveart C; Cosson A; Fenaux P; Preudhomme C
Leukemia; 2002 Jan; 16(1):150-1. PubMed ID: 11840275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
